These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19485802)

  • 1. Molecular markers and hepatocellular carcinoma: lending a helping hand in liver transplantation?
    Dai Z; Yu L; Zhou J; Qiu SJ; Fan J
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):211-3. PubMed ID: 19485802
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular tools and hepatocellular carcinoma: Adding help or confusion in liver transplantation?
    Vibert E; Samuel D
    J Hepatol; 2008 Oct; 49(4):498-501. PubMed ID: 18678433
    [No Abstract]   [Full Text] [Related]  

  • 3. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
    Kaido T; Takada Y; Uemoto S
    Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
    [No Abstract]   [Full Text] [Related]  

  • 4. Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.
    Kneteman N; Livraghi T; Madoff D; de Santibañez E; Kew M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S117-27. PubMed ID: 21584926
    [No Abstract]   [Full Text] [Related]  

  • 5. [Liver transplantation for hepatocellular carcinoma].
    Tanaka A; Tanaka K; Kaihara S; Ueda M; Uemoto S; Kiuchi T; Egawa H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():705-16. PubMed ID: 11762042
    [No Abstract]   [Full Text] [Related]  

  • 6. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma.
    Reddy MS; Manas DM
    Transplantation; 2007 Feb; 83(3):367-8. PubMed ID: 17297420
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive markers for postsurgical recurrence of hepatocellular carcinoma.
    Gao ZH
    J Surg Oncol; 2005 Dec; 92(4):274-5. PubMed ID: 16299794
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver resection and liver transplantation in hepatocellular carcinoma.
    Franco D
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S94. PubMed ID: 8986104
    [No Abstract]   [Full Text] [Related]  

  • 9. Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
    Gouw AS; Balabaud C; Kusano H; Todo S; Ichida T; Kojiro M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S72-80. PubMed ID: 21714066
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver transplantation for hepatocellular carcinoma: status quo and experience in Kyushu University].
    Soejima Y; Taketomi A; Ikegami T; Yoshizumi T; Uchiyama H; Gion T; Sugimachi K; Nagata S; Maehara Y
    Fukuoka Igaku Zasshi; 2008 May; 99(5):95-101. PubMed ID: 18788452
    [No Abstract]   [Full Text] [Related]  

  • 11. Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma.
    Marsh JW; Casavilla A; Iwatsuki S; Dvorchik I; Subotin M; Balan V; Rakela J; Subbotin V; Popechitelev EP
    Hepatology; 1997 Dec; 26(6):1689-91. PubMed ID: 9398022
    [No Abstract]   [Full Text] [Related]  

  • 12. Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted?
    Ringe B
    Hepatology; 1997 Aug; 26(2):507-8. PubMed ID: 9252168
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver transplantation for hepatocellular carcinoma: the hepatitis C quandary.
    Yao FY
    Liver Transpl; 2007 Jun; 13(6):783-5. PubMed ID: 17538996
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expression and clinical significance of anti-apoptotic factors PED/PEA-15 and XIAP in hepatocellular carcinoma].
    Sun DG; Wu YF; Gao ZM; Liang R; Wang LM
    Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(24):1660-4. PubMed ID: 20979872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage live donor liver transplantation for a second recurrence of hepatocellular carcinoma.
    Sotiropoulos GC; Treckmann JW; Molmenti EP; Schmitz KJ; Cicinnati VR; Paul A; Broelsch CE; Malagó M
    Transpl Int; 2008 Feb; 21(2):182-5. PubMed ID: 17971034
    [No Abstract]   [Full Text] [Related]  

  • 16. [Strategy to improve the prognosis of liver transplantation for hepatocellular carcinoma].
    Fan J; Xu Y
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1602-5. PubMed ID: 19094749
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor?
    Schwartz M; Konstadoulakis M; Roayaie S
    Liver Transpl; 2005 May; 11(5):494-6. PubMed ID: 15838915
    [No Abstract]   [Full Text] [Related]  

  • 18. Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries?
    Audet M; Panaro F; Piardi T; Wolf P
    Liver Transpl; 2009 Jul; 15(7):822-3; author reply 824-6. PubMed ID: 19562722
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence.
    Shi YH; Ding WX; Zhou J; He JY; Xu Y; Gambotto AA; Rabinowich H; Fan J; Yin XM
    Hepatology; 2008 Aug; 48(2):497-507. PubMed ID: 18666224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To biopsy or not to biopsy?
    Perkins JD
    Liver Transpl; 2006 May; 12(5):885-6. PubMed ID: 16708420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.